InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-08-07 | Valerie Hoyle(D-OR04) | house | Sale | $1,001 - $15,000 |
| 2024-09-03 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2024-08-30 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2024-04-15 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2024-03-14 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
No financial data available for BNTX.
Company may not file with SEC or CIK is unresolved.
BioNTech Non-GAAP EPS of -€1.95, revenue of €118.1M; reaffirms FY26 outlook
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
Here are the major earnings before the open Tuesday
FDA said to have named Katherine Szarama as acting CBER chief
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models
Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer
BioNTech (BNTX) Price Target Raised Following Successful T-Pam Data
COVID vaccine report on cutting hospital visits blocked from publication in CDC journal
BioNTech (BNTX) Surges 6.1%: Is This an Indication of Further Gains?
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026